ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

June 24, 2020
Review
Open Access

The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review

Frontiers in Neurology
Sheng-Ta TsaiChon-Haw Tsai
July 8, 2020

Neuropathological profile of long duration amyotrophic lateral sclerosis in military Veterans

Brain Pathology
Keith R SpencerThor D Stein
July 6, 2020
Open Access

C9orf72 arginine-rich dipeptide repeats inhibit UPF1-mediated RNA decay via translational repression

Nature Communications
Yu SunJunjie U Guo
June 12, 2020

Polyneuritis cranialis and vasculopathy caused by varicella zoster virus without rash

Acta neurologica Belgica
Ibrahim LabbadRawad Maksoud
July 9, 2020

Targeted next-generation sequencing study in familial ALS-FTD Portuguese patients negative for C9orf72 HRE

Journal of Neurology
Marta GromichoMamede de Carvalho
June 17, 2020
Open Access

Extension of the phenotypic spectrum of GLE1-related disorders to a mild congenital form resembling congenital myopathy

Molecular Genetics & Genomic Medicine
Mathieu CerinoBrigitte Chabrol
July 1, 2020

Central motor conduction time reveals upper motor neuron involvement masked by lower motor neuron impairment in a significant portion of patients with amyotrophic lateral sclerosis

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Ryo TokimuraYoshikazu Ugawa
July 9, 2020
Review

Modern approaches in gene therapy of motor neuron diseases

Medicinal Research Reviews
Maria Zakharova
June 17, 2020

Calculation of the prevalence of progressive muscular atrophy among adults in China based on urban medical insurance data from 15 provinces

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
L XuS F Wang
June 25, 2020
Comment / Editorial

Prognostic value of weight loss in patients with amyotrophic lateral sclerosis

Journal of Neurology, Neurosurgery, and Psychiatry
Frederik J Steyn, Shyuan T Ngo
June 26, 2020
Review
Open Access

Therapeutic Approaches Targeting Protein Aggregation in Amyotrophic Lateral Sclerosis

Frontiers in Molecular Neuroscience
Ravinder Malik, Martina Wiedau
June 13, 2020

TDP-1/TDP-43 potentiates human α-Synuclein (HASN) neurodegeneration in Caenorhabditis elegans

Biochimica Et Biophysica Acta. Molecular Basis of Disease
Linjing ShenGarry Wong
July 2, 2020

The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring

Journal of Neurology, Neurosurgery, and Psychiatry
Umberto ManeraAdriano Chiò
July 2, 2020
Open Access

Neuronal RNA-binding protein dysfunction in multiple sclerosis cortex

Annals of Clinical and Translational Neurology
Hannah E SalapaMichael C Levin
June 13, 2020
Review

Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis

Materials Today. Bio
G Y WangX J Liang
June 13, 2020
Open Access

Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2

Journal of Neurovirology
Paolo ManganottiRoberto Luzzati

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/als---phenotypes/acd563f7-12ae-43e9-8e0c-333a42dde3c3